Acacia Research Corporation (ACTG) insiders have most recently took part in a trading activity. On Sep 15, 2017 Treska Edward Joseph, Exec VP, Gen Counsel & Sec bought 2,500 shares having total worth of $9,950 at the price of $3.98 per share, following the transaction a total of 56,035 shares owned by Treska Edward Joseph.
On the same day, Stewart Robert B Jr, President bought 5,000 shares having total worth of $20,050 at the price of $4.01 per share, following the transaction a total of 100,687 shares owned by Stewart Robert B Jr.
On the same day, Haynes Clayton J, CFO bought 2,000 shares having total worth of $7,980 at the price of $3.99 per share, following the transaction a total of 96,922 shares owned by Haynes Clayton J.
On the same day, Graziadio G Louis Iii, Director bought 32,900 shares having total worth of $131,929 at the price of $4.01 per share, following the transaction a total of 999,551 shares owned by Graziadio G Louis Iii. Before this latest buy, Graziadio G Louis Iii purchased ACTG at 12 other times during the past twelve months, for a total investment of $11.57M at an average of $3.81 per share.
The stock has experienced a total of 10 insider trades in the past three months. These trades include 10 buy trades. Furthermore, over the past 12 months , the stock was traded 15 times by insiders. an employee of the company was the buyer in 15 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Acacia Research Corporation (ACTG) last announced its earnings results on Jul 27, 2017. The company reported -0.14 earnings per share (EPS) for the quarter, lower than the consensus estimate of 0.08 by $0.22. The company had revenue of $16 million for the quarter, compared to the consensus estimate of $20 million. During the same quarter in the previous year, the company posted 0.23 earnings per share. The company’s revenue for the quarter was down 60% on a year-over-year basis.
|earnings per share||-0.14||-0.08||0.02||0.31||0.23||0.05||0.09||-0.23||0.25||0.06|
Acacia Research Corporation was originally incorporated in California in January 1993 and reincorporated in Delaware in December 1999. The Company through its operating subsidiaries acquires, develops, licenses and enforces patented technologies. The Company’s operating subsidiaries generate license fee revenues and related cash flows from the granting of licenses for the use of patented technologies that its operating subsidiaries own or control. The operating subsidiaries assist patent owners with the prosecution and development of their patent portfolios, the protection of their patented inventions from unauthorized use, the generation of licensing revenue from users of their patented technologies and, if necessary, with the enforcement against unauthorized users of their patented technologies. The Company is in the business of licensing patented technologies and has processed over 1,225 license agreements execution to date, across 143 of its technology license programs. Currently, on a consolidated basis, the company’s operating subsidiaries own or control the rights to over 250 patent portfolios, which include U.S. patents and certain foreign counterparts, covering technologies used in a variety of industries.
Latest posts by William White (see all)
- Insider Trading Activity in: Second Sight Medical Products, Inc. $EYES - July 19, 2018
- Insider Trading Activity in: Internationa Flavors & Fragrances, Inc. $IFF - July 19, 2018
- Insider Trading Update: Opko Health, Inc. $OPK - July 19, 2018